News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Knopp NeuroSciences Initiates Phase 2 Study of KNS-760704 in Amyotrophic Lateral Sclerosis



4/7/2008 9:15:39 AM

PITTSBURGH--(BUSINESS WIRE)--Knopp Neurosciences Inc. (“Knopp”) said it initiated the first Phase 2 study of KNS-760704 in patients with amyotrophic lateral sclerosis (ALS).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES